Business & Finance
Illumina CEO on Genomic Sequencing Opportunities and AI
Key Points
Jul 31st, 2026 Illumina CEO on Genomic Sequencing Opportunities and AI Illumina CEO Jacob Thaysen discusses the company's earnings, genomic medicine opportunities and the potential for artificial intelligence in life sciences on "Bloomberg The Close."
Jul 31st, 2026
Illumina CEO on Genomic Sequencing Opportunities and AI
Illumina CEO Jacob Thaysen discusses the company's earnings, genomic medicine opportunities and the potential for artificial intelligence in life sciences on "Bloomberg The Close."